Sorrento Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
12.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.25
|
0.00
|
0.25
|
100.00%
|
|
2022-09-30
|
-0.25
|
-0.20
|
0.05
|
20.00%
|
|
2022-06-30
|
-0.25
|
-0.54
|
-0.29
|
-116.00%
|
|
2022-03-31
|
-0.17
|
-0.12
|
0.05
|
29.41%
|
|
2021-12-31
|
-0.29
|
-0.47
|
-0.18
|
-62.07%
|
|
2021-09-30
|
-0.23
|
-0.40
|
-0.17
|
-73.91%
|
|
2021-06-30
|
-0.20
|
-0.57
|
-0.37
|
-185.00%
|
|
2021-03-31
|
0.38
|
0.01
|
-0.37
|
-97.37%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.86
|
|
2021-12-31
|
-1.43
|
|
2020-12-31
|
-1.32
|
|
2019-12-31
|
-2.25
|
|
2018-12-31
|
-1.92
|
|
2017-12-31
|
0.37
|
|
2016-12-31
|
-1.57
|
|
2015-12-31
|
-1.24
|
|
2014-12-31
|
-1.54
|
|
2013-12-31
|
-1.46
|
|
2012-12-31
|
-0.43
|
|
2011-12-31
|
-0.33
|
|
2010-12-31
|
-0.24
|